Back to Search
Start Over
Valproic acid and lamotrigine treatment during pregnancy. The risk of chromosomal abnormality.
- Source :
-
Mutation research [Mutat Res] 2003 Jan 10; Vol. 534 (1-2), pp. 197-9. - Publication Year :
- 2003
-
Abstract
- A baby born to an epileptic mother had dysmorphological features associated with 47,XXX karyotype. The mother had been treated with valproic acid (1800mg per day) and lamotrigine (100mg per day) throughout pregnancy. Dysmorphological features detected in baby were intrauterine growth retardation, hypertelorism, flattened nasal bridge, low set malformed auriculas, micrognathia, very small an bow-shaped mouth with thin upper lip, cleft palate, arachnodactyly, camptodactyly, secundum atrial septal defect, bilateral hammer toes and decreased creases on the soles. At 6 months old she showed motor retardation. The molecular analysis of parents revealed that extra X chromosome was inherited from the mother. In this case whether the dysmorphological features and 47,XXX karyotype were caused by lamotrigine and valproic acid treatment during pregnancy or coincidence is in question.
- Subjects :
- Abnormalities, Drug-Induced genetics
Abnormalities, Multiple genetics
Adult
Anticonvulsants adverse effects
Cleft Palate chemically induced
Cleft Palate genetics
Female
Fetal Growth Retardation chemically induced
Fetal Growth Retardation genetics
Humans
Infant
Infant, Newborn
Karyotyping
Lamotrigine
Pedigree
Pregnancy
Abnormalities, Multiple chemically induced
Chromosome Aberrations chemically induced
Chromosomes, Human, X drug effects
Epilepsy drug therapy
Pregnancy Complications drug therapy
Prenatal Exposure Delayed Effects
Triazines adverse effects
Valproic Acid adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 0027-5107
- Volume :
- 534
- Issue :
- 1-2
- Database :
- MEDLINE
- Journal :
- Mutation research
- Publication Type :
- Academic Journal
- Accession number :
- 12504768
- Full Text :
- https://doi.org/10.1016/s1383-5718(02)00254-1